Facial Plast Surg 2022; 38(01): 081-087
DOI: 10.1055/s-0041-1730387
Original Research

The Effects of Vasonatrin Peptide on Fat Graft Viability: An Experimental Study

Fatih Irmak
1   Fatih Irmak Clinic, Istanbul, Turkey
,
2   Department of Plastic, Reconstructive and Aesthetic Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
,
Selami Serhat Sirvan
2   Department of Plastic, Reconstructive and Aesthetic Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
,
Semra Karsidag
2   Department of Plastic, Reconstructive and Aesthetic Surgery, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
,
Aysim Ozagari
3   Department of Pathology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey
› Author Affiliations
Funding This study was supported by Sağlık Bilimleri Üniversitesi Bilimsel Araştırma Projeleri, Istanbul Health Sciences University, Projects of Scientific Research, Istanbul (2018/047).

Abstract

Vasonatrin peptide (VNP) is a synthetic peptide that possesses vasodilatory, natriuretic, and anti-inflammatory properties. The authors aimed to analyze the effects of VNP on fat graft survival. Twenty Sprague–Dawley rats are randomly divided into two groups of 10. Fat grafts are harvested from the right inguinal region. After preparation, fat grafts are placed to the interscapular region. The first group of rats were administered VNP after their fat injection, while the second group received tail-vein injections of an equal volume of sterile saline following their fat injection. Experiment and control groups are evaluated according to their level of degeneration of adipocytes, fat necrosis, vacuolization, cyst formation in adipocytes, fibrosis of the fat tissue, capillary density, and CD31 immunohistochemical staining. Degeneration, vacuolization, and cyst formation in adipocytes were lower in the experiment group. Increased capillary density in the experiment group was demonstrated by CD31 antibody staining and by counting capillary density under a microscope. The average percentage of change in weight of the fat grafts in the experiment group was lower than that in the control group. The results indicate that VNP has some beneficial effects on fat graft survival by multiple independent mechanisms that influence both local and systemic homeostasis.



Publication History

Article published online:
07 June 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wei CM, Kim CH, Miller VM, Burnett Jr JC. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest 1993; 92 (04) 2048-2052
  • 2 Neubar GA. Verhandlugen der Deutschen Gesellschaft für Chirurgie [in German]. 1893; 1: 66
  • 3 Marten TJ, Elyassnia D. Fat grafting in facial rejuvenation. Clin Plast Surg 2015; 42 (02) 219-252
  • 4 Hoang D, Orgel MI, Kulber DA. Hand rejuvenation: a comprehensive review of fat grafting. J Hand Surg Am 2016; 41 (05) 639-644
  • 5 Trivisonno A, Rossi A, Monti M. et al. Facial skin rejuvenation by autologous dermal microfat transfer in photoaged patients: clinical evaluation and skin surface digital profilometry analysis. J Plast Reconstr Aesthet Surg 2017; 70 (08) 1118-1128
  • 6 Eto H, Kato H, Suga H. et al. The fate of adipocytes after nonvascularized fat grafting: evidence of early death and replacement of adipocytes. Plast Reconstr Surg 2012; 129 (05) 1081-1092
  • 7 Pu LL. Mechanisms of fat graft survival. Ann Plast Surg 2016; 77 (Suppl. 01) S84-S86
  • 8 Lu SY, Wang DS, Zhu MZ, Zhang QH, Hu YZ, Pei JM. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells. Life Sci 2005; 77 (01) 28-38
  • 9 Nishimura T, Hashimoto H, Nakanishi I, Furukawa M. Microvascular angiogenesis and apoptosis in the survival of free fat grafts. Laryngoscope 2000; 110 (08) 1333-1338
  • 10 Delay E, Garson S, Tousson G, Sinna R. Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years. Aesthet Surg J 2009; 29 (05) 360-376
  • 11 Kølle SF, Fischer-Nielsen A, Mathiasen AB. et al. Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet 2013; 382 (9898): 1113-1120
  • 12 Zielins ER, Brett EA, Longaker MT, Wan DC. Autologous fat grafting: the science behind the surgery. Aesthet Surg J 2016; 36 (04) 488-496
  • 13 Landau MJ, Birnbaum ZE, Kurtz LG, Aronowitz JA. Review: proposed methods to improve the survival of adipose tissue in autologous fat grafting. Plast Reconstr Surg Glob Open 2018; 6 (08) e1870
  • 14 Rinker BD, Vyas KS. Do stem cells have an effect when we fat graft?. Ann Plast Surg 2016; 76 (Suppl. 04) S359-S363
  • 15 Yoshimura K, Shigeura T, Matsumoto D. et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006; 208 (01) 64-76
  • 16 Tan SS, Ng ZY, Zhan W, Rozen W. Role of adipose-derived stem cells in fat grafting and reconstructive surgery. J Cutan Aesthet Surg 2016; 9 (03) 152-156
  • 17 Charles-de-Sá L, Gontijo-de-Amorim NF, Maeda Takiya C. et al. Antiaging treatment of the facial skin by fat graft and adipose-derived stem cells. Plast Reconstr Surg 2015; 135 (04) 999-1009
  • 18 Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008; 122 (05) 1352-1360
  • 19 Li F, Guo W, Li K. et al. Improved fat graft survival by different volume fractions of platelet-rich plasma and adipose-derived stem cells. Aesthet Surg J 2015; 35 (03) 319-333
  • 20 Seyhan N, Alhan D, Ural AU, Gunal A, Avunduk MC, Savaci N. The effect of combined use of platelet-rich plasma and adipose-derived stem cells on fat graft survival. Ann Plast Surg 2015; 74 (05) 615-620
  • 21 Krumboeck A, Giovanoli P, Plock JA. Fat grafting and stem cell enhanced fat grafting to the breast under oncological aspects--recommendations for patient selection. Breast 2013; 22 (05) 579-584
  • 22 Temiz G, Sirinoglu H, Yesiloglu N, Filinte D, Kaçmaz C. Effects of deferoxamine on fat graft survival. Facial Plast Surg 2016; 32 (04) 438-443
  • 23 Phipps KD, Gebremeskel S, Gillis J, Hong P, Johnston B, Bezuhly M. Alternatively activated M2 macrophages improve autologous fat graft survival in a mouse model through induction of angiogenesis. Plast Reconstr Surg 2015; 135 (01) 140-149
  • 24 Fontdevila J, Guisantes E, Martínez E, Prades E, Berenguer J. Double-blind clinical trial to compare autologous fat grafts versus autologous fat grafts with PDGF: no effect of PDGF. Plast Reconstr Surg 2014; 134 (02) 219e-230e
  • 25 Jiang A, Li M, Duan W, Dong Y, Wang Y. Improvement of the survival of human autologous fat transplantation by adipose-derived stem-cells-assisted lipotransfer combined with bFGF. ScientificWorldJournal 2015; 2015: 968057
  • 26 Medina III MA, Nguyen JT, Kirkham JC. et al. Polymer therapy: a novel treatment to improve fat graft viability. Plast Reconstr Surg 2011; 127 (06) 2270-2282
  • 27 Kuramochi D, Unoki H, Bujo H. et al. Matrix metalloproteinase 2 improves the transplanted adipocyte survival in mice. Eur J Clin Invest 2008; 38 (10) 752-759
  • 28 Morishita Y, Sano T, Ando K. et al. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun 1991; 176 (03) 949-957
  • 29 Wennberg PW, Miller VM, Rabelink T, Burnett Jr JC. Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism. Am J Physiol 1999; 277 (04) H1618-H1621
  • 30 Klinger JR, Warburton R, Carino GP. et al. Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in pulmonary microvascular endothelial cells. Exp Cell Res 2006; 312 (04) 401-410
  • 31 Yu J, Zhu MZ, Wei GZ. et al. Vasorelaxing role of vasonatrin peptide in human intramammary artery in vitro [in Chinese]. Sheng Li Xue Bao 2003; 55 (02) 187-190
  • 32 Feng HS, Zang YM, Zhu MZ. et al. Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide [in Chinese]. Sheng Li Xue Bao 1999; 51 (05) 515-520
  • 33 Garza RM, Paik KJ, Chung MT. et al. Studies in fat grafting: Part III. Fat grafting irradiated tissue--improved skin quality and decreased fat graft retention. Plast Reconstr Surg 2014; 134 (02) 249-257
  • 34 Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006; 27 (01) 47-72
  • 35 Scotland RS, Cohen M, Foster P. et al. C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc Natl Acad Sci U S A 2005; 102 (40) 14452-14457
  • 36 Ohno N, Itoh H, Ikeda T. et al. Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation 2002; 105 (14) 1623-1626
  • 37 Lu SY, Zhu MZ, Wang DS. et al. Inhibition of the proliferation of smooth muscle cells from human coronary bypass vessels by vasonatrin peptide. Physiol Res 2004; 53 (04) 387-393
  • 38 von Lueder TG, Sangaralingham SJ, Wang BH. et al. Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure. Circ Heart Fail 2013; 6 (03) 594-605
  • 39 Bordicchia M, Liu D, Amri EZ. et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012; 122 (03) 1022-1036
  • 40 Wang SP, Lan ZY, Xia W. et al. The effects of vasonatrin peptide on random pattern skin flap survival. Ann Plast Surg 2014; 72 (01) 94-99
  • 41 Chen BY, Qu P, Tie R, Zhu MZ, Zhu XX, Yu J. Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis. Regul Pept 2010; 164 (2–3): 139-143
  • 42 Bravo R, Parra V, Gatica D. et al. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol 2013; 301: 215-290
  • 43 Shi Z, Fu F, Yu L. et al. Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms. Am J Physiol Heart Circ Physiol 2015; 308 (04) H281-H290